Amarin Corp Plc (AMRN)

[sstyles]

The larger point is that it's brilliant because the lawsuit creates a downward spiral for Hikma.

The more aggressive Hikma is with producing generic Vascepa....the likelier they are to infringe on the Reduce-IT indication. The more infringement....the easier the path to show liability / damages.

This will not end well. Hikma can decide it's fate. The more aggressive....the more damages.